<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptor gamma (PPARgamma) has been shown to protect against <z:hpo ids='HP_0001297'>stroke</z:hpo> and improve neurological outcome after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This study investigated whether activation of cerebral PPARgamma improves recovery from focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by reducing expression of cyclin D1, which is associated with programmed neuron <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced by 90 min of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), followed by reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Intracerebroventricular (i.c.v.) infusion of the PPARgamma <z:chebi fb="4" ids="48705">agonist</z:chebi> ciglitazone, beginning 5 days before and continuing through 1 day after MCAO, reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size and cyclin D1 expression in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> cortical region </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, primary cortical neurons treated with ciglitazone showed suppressed expression of cyclin D1 in response to <z:mp ids='MP_0005039'>hypoxia</z:mp>-reoxygenation </plain></SENT>
<SENT sid="5" pm="."><plain>This protective effect was reversed after cotreatment with the selective PPAR-gamma <z:chebi fb="68" ids="48706">antagonist</z:chebi> GW 9662 (2-chloro-5-nitrobenzanilide), clearly demonstrating the involvement of a PPARgamma-dependent mechanism </plain></SENT>
<SENT sid="6" pm="."><plain>Our data provide evidence that activation of neuronal PPARgamma makes a substantial contribution to neuroprotection by preventing cyclin D1 up-regulation in vitro and in vivo </plain></SENT>
</text></document>